{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:23:31Z","timestamp":1790879011242,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.autrev.2007.01.003","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T07:53:21Z","timestamp":1170489201000},"page":"379-386","source":"Crossref","is-referenced-by-count":95,"title":["Cardiac manifestations in antiphospholipid syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"P\u00e1l","family":"Solt\u00e9sz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2007.01.003_bib1","first-page":"1546","article-title":"Antiphospholipid antibody syndrome","volume":"vol. 2","author":"Roubey","year":"2001"},{"key":"10.1016\/j.autrev.2007.01.003_bib2","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2007.01.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"7 Suppl","key":"10.1016\/j.autrev.2007.01.003_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/096120339800700231","article-title":"Atherosclerosis and the antiphospholipid syndrome: a link unraveled?","author":"Shoenfeld","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/CRIAI:25:1:79","article-title":"Atherosclerosis and antiphospholipid syndrome","volume":"25","author":"Jara","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2007.01.003_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/jaut.2000.0405","article-title":"Recent advances in antiphospholipid antibody-related valvulopathies","volume":"15","author":"Cervea","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2007.01.003_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.thromres.2004.06.026","article-title":"Coronary and valvular syndromes and antiphospholipid antibodies","volume":"114","author":"Cervera","year":"2004","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.autrev.2007.01.003_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.003_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1385\/CRIAI:23:3:341","article-title":"Cardiac valvulopathy in the antiphospholipid syndrome","volume":"23","author":"Lev","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2007.01.003_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0002-8703(92)90420-Z","article-title":"Cardiac manifestations of the antiphospholipid syndrome","volume":"124","author":"Kaplan","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.autrev.2007.01.003_bib11","first-page":"171","article-title":"Cardiac manifestations of the antiphospholipid antibody syndrome: a review","volume":"99","author":"Nayak","year":"2002","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1191\/0961203305lu2202oa","article-title":"Cardiac involvement in the antiphospholipid syndrome","volume":"14","author":"Tenedios","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"issue":"Suppl I","key":"10.1016\/j.autrev.2007.01.003_bib14","first-page":"37","article-title":"Autoantibodies associated with atherosclerosis","volume":"32","author":"Shoenfeld","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/096120339600500522","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"5","author":"Vaarala","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1191\/0961203304lu1011oa","article-title":"Antiphospholipid antibodies in acute coronary syndrome","volume":"13","author":"Veres","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.ATV.20.1.204","article-title":"Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease","volume":"20","author":"Erkkila","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2007.01.003_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2005.02.026","article-title":"Antibodies against oxidized LDL anticardiolipin and mortality in patients with coronary heart disease","volume":"183","author":"Erkkila","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.autrev.2007.01.003_bib19","unstructured":"D\u00e9r H, Kerekes G, Veres K, T\u00f3th J, Lakos G, Muszbek L, Szegedi G, Solt\u00e9sz P. Decreased flow-mediated vasodilation and increased von Willebrand antigen level is associated with early signs of atherosclerosis in patients with primary antiphospholipid syndrome. Lupus, in press."},{"key":"10.1016\/j.autrev.2007.01.003_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/096120339500400413","article-title":"The presence of antiphospholipid antibodies in acute myocardial infarction","volume":"4","author":"Adler","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1365-2168.1999.0702b.x","article-title":"Vascular surgical society of Great Britain and Ireland: prevalence and significance of thrombophilia in patients with intermittent claudication","volume":"86","author":"Evans","year":"1999","journal-title":"Br J Surg"},{"key":"10.1016\/j.autrev.2007.01.003_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.60.7.699","article-title":"Severe atherosclerotic changes including aortic occlusion, associated with hyperhomocysteinemia and antiphospholipid antibodies","volume":"60","author":"Spronk","year":"2001","journal-title":"Ann Reum Dis"},{"key":"10.1016\/j.autrev.2007.01.003_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.berh.2005.05.001","article-title":"Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?","volume":"19","author":"Bruce","year":"2005","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.003_bib24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/circ.104.16.1876","article-title":"Atherosclerosis, autoimmunity and systemic lupus erythematosus","volume":"104","author":"Thiagarajan","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2007.01.003_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jimenez","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2007.01.003_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1191\/0961203303lu339oa","article-title":"Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients","volume":"12","author":"Soltesz","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1536\/ihj.46.631","article-title":"Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome","volume":"46","author":"Gurlek","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.autrev.2007.01.003_bib28","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","article-title":"Low density lipoprotein undergoes oxidative modification in vivo","volume":"86","author":"Palinski","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2007.01.003_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/10446670310001642113","article-title":"IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome","volume":"10","author":"Lopez","year":"2003","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2007.01.003_bib30","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.99.17.2227","article-title":"Immunolocalization of \u03b22-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: Potential implications for lesion progression","volume":"99","author":"George","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2007.01.003_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000028046","article-title":"Enhancement of atherosclerosis in berta-2-glycoprotein I-immunized apolipoprotein E-deficient mice","volume":"67","author":"Afek","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/j.autrev.2007.01.003_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1590\/S0004-282X2003000500010","article-title":"Antibodies to the atherosclerotic plaque components beta2 glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemia","volume":"61","author":"Staub","year":"2003","journal-title":"Arq Neuro Psiquiatr"},{"key":"10.1016\/j.autrev.2007.01.003_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/HAB-1999-9206","article-title":"Anti-cardiolipin, anti-endothelial cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis","volume":"9","author":"George","year":"1999","journal-title":"Hum Antib"},{"key":"10.1016\/j.autrev.2007.01.003_bib34","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","article-title":"Are anti-oxLDL antibodies pathogenic or protective?","volume":"110","author":"Shoenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2007.01.003_bib35","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.CIR.98.11.1108","article-title":"Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with \u03b22-glycoprotein I","volume":"98","author":"George","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2007.01.003_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.autrev.2005.08.008","article-title":"Premature atherosclerotic disease in systemic lupus erythematosus-role of inflammatory mechanisms","volume":"5","author":"Rhew","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.01.003_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2007.01.003_bib38","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1161\/01.CIR.102.21.2576","article-title":"Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction","volume":"102","author":"Mustafa","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2007.01.003_bib39","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0022-2275(20)31518-2","article-title":"Immune complexes and IFN-gamma decrease cholesterol-27-hydroxylase in human arterial endothelium and macrophages","volume":"42","author":"Reiss","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2007.01.003_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.003_bib42","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib43","unstructured":"Solt\u00e9sz P, D\u00e9r H, Kerekes Gy, et al. Endothelial dysfunction, early and accelerated atherosclerosis in systemic autoimmune diseases. Orv Hetil (Hung Med J), in press."},{"key":"10.1016\/j.autrev.2007.01.003_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib45","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jimenez","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2007.01.003_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.62.7.607","article-title":"Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome","volume":"62","author":"Medina","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.01.003_bib47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.imbio.2005.10.006","article-title":"Predictive role of hs-C-reactive protein in patients with antiphospholipid syndrome","volume":"210","author":"Miesbach","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2007.01.003_bib48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1191\/0961203303lu391oa","article-title":"Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report","volume":"12","author":"Lockshin","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1191\/0961203303lu2135oa","article-title":"Statins: immunomodulators for autoimmune rheumatic disease?","volume":"14","author":"Jury","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keg436","article-title":"Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management","volume":"43","author":"Wajed","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2007.01.003_bib51","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/archinte.160.13.2042","article-title":"Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks?","volume":"160","author":"Wahl","year":"2000","journal-title":"Arch Int Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib52","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0049-3848(82)90241-9","article-title":"Prevention of the platelet alpha-granule release reaction by membrane-active drugs","volume":"25","author":"Prowse","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2007.01.003_bib55","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"Espinola","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2007.01.003_bib56","first-page":"532","article-title":"Antiphospholipid syndrome. The use of transesophageal echocardiography","volume":"20","author":"Cervera-Miguel","year":"2003","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.autrev.2007.01.003_bib57","first-page":"39","article-title":"Involvement of cardiac valves in antiphospholipid syndrome","volume":"74","author":"Sergakova","year":"1996","journal-title":"Klin Med (Mosk)"},{"key":"10.1016\/j.autrev.2007.01.003_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000176663","article-title":"Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome","volume":"85","author":"Metz","year":"1994","journal-title":"Cardiology"},{"key":"10.1016\/j.autrev.2007.01.003_bib59","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0735-1097(92)90368-W","article-title":"Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies","volume":"20","author":"Roldan","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2007.01.003_bib60","first-page":"597","article-title":"Association of lupus anticoagulant with severe valvular heart disease in SLE","volume":"15","author":"Ford","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.003_bib61","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.1924.00110300044002","article-title":"A hitherto undescribed form of valvular and mural endocarditis","volume":"33","author":"Libman","year":"1924","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0002-9343(88)80236-5","article-title":"Clinically significant valvular heart disease in systemic lupus erythematosus","volume":"85","author":"Straaton","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2007.01.003_bib63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.thromres.2004.06.039","article-title":"Libman\u2013Sacks endocarditis associated with antiphospholipid syndrome and infection","volume":"114","author":"Blank","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2007.01.003_bib64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/096120339600500306","article-title":"Libman\u2013Sacks endocarditis in the antiphospholipid syndrome","volume":"5","author":"Ziporen","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1191\/0961203305lu2203oa","article-title":"From rheumatic fever to Libman\u2013Sacks endocarditis: is there any possible pathogenetic link?","volume":"14","author":"Blank","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2007.01.003_bib66","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-8703(95)90124-8","article-title":"Diastolic dysfunction is a feature of the antiphospholipid syndrome","volume":"129","author":"Hasnie","year":"1995","journal-title":"Am Heart J"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T09:18:28Z","timestamp":1628414308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997207000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1568997207000146"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2007.01.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}